As protein-protein interactions connect proteins that participate in either the same or different functions, networks of interacting and functionally annotated proteins can be converted into process graphs of inter-dependent function nodes (each node corresponding to interacting proteins with the same functional annotation). However, as proteins have multiple annotations, the process graph is non-redundant, if only proteins participating directly in a given function are included in the related function node.
Univariate conditional models are of core importance in supporting medical reasoning, as they allow to decompose a joint probability distribution using the chain rule. Although several methods are available for the elicitation of the joint prior distribution of parameters when the response is a medical categorical variable, the case of a medical continuous response is typically difficult to address, because its sample space is often bounded to an interval and its relationship with explanatory variables may be not linear. In these situations, the elicitation of an informative prior distribution on parameters of a univariate conditional model is challenging, because some level of statistical training is required to a medical expert for interpreting parameters and for retrieving appropriate quantitative information about them. The task can be eased and made efficient by recognizing that physicians typically distinguish among values involving medically normal and pathological patient conditions on the grounds of their personal clinical experience. In this paper, we propose a Generalized Beta regression where parameter elicitation is performed by establishing a correspondence among measured values expressed as relative positions within intervals with a clinical interpretation, regardless the original scales of variables. Software implementing the elicitation procedure is freely available.
Several tons of chemicals are released every year into the environment and it is essential to assess the risk of adverse effects on human health and ecosystems. Risk assessment is expensive and time-consuming and only partial information is available for many compounds. A consolidated approach to overcome this limitation is the Threshold of Toxicological Concern (TTC) for assessment of the potential health impact and, more recently, eco-TTCs for the ecological aspect. The aim is to allow a safe assessment of substances with poor toxicological characterization. Only limited attempts have been made to integrate the human and ecological risk assessment procedures in a “One Health” perspective. We are proposing a strategy to define the Human-Biota TTCs (HB-TTCs) as concentrations of organic chemicals in freshwater preserving both humans and ecological receptors at the same time. Two sets of thresholds were derived: general HB-TTCs as preliminary screening levels for compounds with no eco- and toxicological information, and compound-specific HB-TTCs for chemicals with known hazard assessment, in terms of Predicted No effect Concentration (PNEC) values for freshwater ecosystems and acceptable doses for human health. The proposed strategy is based on freely available public data and tools to characterize and group chemicals according to their toxicological profiles. Five generic HB-TTCs were defined, based on the ecotoxicological profiles reflected by the Verhaar classes, and compound-specific thresholds for more than 400 organic chemicals with complete eco- and toxicological profiles. To complete the strategy, the use of in silico models is proposed to predict the required toxicological properties and suitable models already available on the VEGAHUB platform are listed.